Friday, November 20, 2026
Welcome from MGB Leadership and Course Directors and Pre-Test Administration
7:00-7:15 am
The Thyroid Nodule in 2026
7:15-7:50 am
Updates in mPTC
7:50-8:10 am
PTC: how large can you go with active surveillance?
8:10-8:30 am
ATC tumor microenvironment and response to therapy
8:30-9:00 am
Break
9:00-9:30 am
ATA nodules guidelines tour: what the clinician needs to know
9:30-9:50 am
RLN manangement in 2026
9:50-10:10 am
Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: an EU consensus statement
10:10-10:30 am
Applying molecular profiling of thyroid neoplasia in clinical practice: from prediction to treatment
10:30-10:50 am
FT-UMP, WDT-UMP, NIFTP: what the clinician needs to know
10:50-11:10 am
Thyroseq for diagnosis and prognosis
11:10-11:30 am
Panel #1 Thyroid Nodules – treatment decisions and Q&A
Moderators: Marika Russell; Sara Ahmadi
Speakers: Runhua Hou; Rajshri Gartland; Mary Beth Cunnane; Natalia Kyriazidis; Michael Otremba; Nancy Cho; Theodora Pappa; William Faquin
11:30 am-12:20 pm
Lunch Break
12:20-1:25 pm
RFA and the RLN: lessons learned from surgical experience
1:25-1:45 pm
De-escalation of thyroid cancer surgery: hemithyroidectomy and lateral neck dissection
1:45-2:05 pm
Risk adaptation and de-escalation in thyroid cancer surveillance
2:05-2:25 pm
Oncytic Cell Carcinoma – Genetics and Management
2:25-2:45 pm
Break
2:45-3:05 pm
Revision surgery for DTC
3:05-3:25 pm
RET-altered thyroid cancer treatment
3:25-3:45 pm
Advanced thyroid cancer: managing treatment toxicity
3:45-4:05 pm
Advanced thyroid cancer surgery
4:05-4:25 pm
Neoadjuvant therapy for advanced disease in 2026
4:25-4:45 pm
Management of BRAF-wild-type ATC: what the clinician needs to know
4:45-5:05 pm
Panel #2: Thyroid Cancer Tumor Board and Q&A
Moderators: Gregory Randolph; Laura Gougen
Speakers: Lori Wirth; Sareh Parangi; Theodora Pappa; Richard Wong; Megan Haymart; Ashok Shaha; Derrick Lin; Ian Witterick; Giuseppe Mercante
5:05-5:45 pm
Saturday, November 21, 2026
Preop evaluation for thyroid cancer surgery
7:00-7:20 am
Radiofrequency ablation of thyroid cancer
7:20-7:40 am
Update in pediatric thyroid cancer genetics
7:40-8:00 am
Kocher Lecuture: Thyroid cancer surgery: 40 years of lessons learned and the people along the way
8:00-8:40 am
Graves Ophthalmopathy in 2026
8:40-9:00 am
Cope Lecture: Changing Paradigms in Hyperparathyroidism
9:00-9:40 am
Break
9:40-9:50 am
Practical office-based US 2026: pearls from a busy practice
9:50-10:10 am
Indeterminant nodule management: Observation, RFA or Surgery?
10:10-10:30 am
Medicolegal issues and burnout
10:30-10:50 am
Management of the neck in thyroid cancer
10:50-11:10 am
Leveraging Neuromonitoring in Thyroid Cancer surgery
11:10-11:30 am
Building an endocrine practice and the new Focused Practice Designation
11:30-11:50 am
Surgery for Graves
11:50 am-12:10 pm
Pediatric thyroid cancer management in 2026
12:10-12:30 pm
Lunch Break
12:30-1:30 pm
Autofluorescence and Parathyroid Vascular Assessment
1:30-1:50 pm
HPT Imaging: 4D CT
1:50-2:10 pm
Essentials of preop HPT evaluation: a surgeon’s perspective
2:10-2:30 pm
Break
2:30-2:50 pm
Normohormonal and normocalcemic HPT
2:50-3:10 pm
Secondary HPT Surgery: When and How Much?
3:10-3:30 pm
Panel #3: Parathyroid Panel
Moderators: Peter Angelos; Gerard Doherty; Antonia Stephen
Speakers: Leslie Eldeiry; Michael Singer; David Shonka; Richard Hodin; Carrie Cunningham; Ben James
3:30-4:10 pm
Closing Remarks
4:10-4:15 pm